Viavi Solutions is trading at €31.60, down 3.28%, on September 24, 2026, with no confirmed company-specific catalyst identified in available coverage.
- Stifel reiterated a Buy rating and $65 price target on September 23, citing progress in co-packaged-optics testing and the DORC acquisition; that action does not clearly explain the decline.
- Broader market futures were modestly lower, while major cash indices were flat, providing limited confirmation of a market-wide cause.